Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases

BACKGROUND: Immune checkpoint inhibitors (ICPIs) are being investigated in clinical trials for patients with glioblastoma. While these therapies hold great promise, management of the patients receiving such treatment can be complicated due to the challenges in recognizing immune-related adverse even...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranjan, Surabhi, Quezado, Martha, Garren, Nancy, Boris, Lisa, Siegel, Christine, Lopes Abath Neto, Osorio, Theeler, Brett J., Park, Deric M., Nduom, Edjah, Zaghloul, Kareem A., Gilbert, Mark R., Wu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831705/
https://www.ncbi.nlm.nih.gov/pubmed/29490632
http://dx.doi.org/10.1186/s12885-018-4131-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831705/
https://www.ncbi.nlm.nih.gov/pubmed/29490632
http://dx.doi.org/10.1186/s12885-018-4131-1

Ejemplares similares